New vaccine aims to protect babies from severe diarrhea
NCT ID NCT06523231
First seen Nov 01, 2025 · Last updated Apr 28, 2026 · Updated 27 times
Summary
This study tested a new vaccine called Shigella4V2 in 110 healthy 9-month-old infants. The goal was to see if it is safe and helps the body build defenses against Shigella bacteria, which causes severe diarrhea. Researchers compared different doses to find the best one for future use.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SHIGELLOSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
KEMRI - Center for Global Health Research
Kisumu, 578,40100, Kenya
Conditions
Explore the condition pages connected to this study.